Polymorphism in interferon λ3/interleukin-28B gene and risk to noncirrhotic chronic hepatitis C genotype 3 virus infection and its effect on the response to combined daclatasvir and sofosbuvir therapy. [electronic resource]
Producer: 20200317Description: 659-667 p. digitalISSN:- 1096-9071
- Adult
- Aged
- Antiviral Agents -- therapeutic use
- Carbamates
- Case-Control Studies
- Female
- Genetic Predisposition to Disease
- Genotype
- Hepacivirus -- classification
- Hepatitis C, Chronic -- drug therapy
- Humans
- Imidazoles -- therapeutic use
- Interferons -- genetics
- Male
- Middle Aged
- Pyrrolidines
- Recurrence
- Sofosbuvir -- therapeutic use
- Sustained Virologic Response
- Treatment Outcome
- Valine -- analogs & derivatives
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.